These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7850052)

  • 1. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors.
    Curtiss SI; Mor E; Schwartz ME; Sung MW; Hytiroglou P; Thung SN; Sheiner PA; Emre S; Miller CM
    J Am Coll Surg; 1995 Feb; 180(2):184-7. PubMed ID: 7850052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is liver transplantation as surgical therapy concept in metastases of neuroendocrine tumors justified?].
    Lang H; Oldhafer KJ; Schlitt HJ; Scheumann GF; Ringe B; Pichlmayr R
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():416-8. PubMed ID: 9101890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
    van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
    Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors.
    Elias D; Lasser P; Rougier P; Ducreux M; Bognel C; Roche A
    J Am Coll Surg; 1995 Feb; 180(2):213-9. PubMed ID: 7850058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic alternatives in metastatic neuroendocrine tumors.
    Miller CA; Ellison EC
    Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors.
    Olausson M; Friman S; Herlenius G; Cahlin C; Nilsson O; Jansson S; Wängberg B; Ahlman H
    Liver Transpl; 2007 Mar; 13(3):327-33. PubMed ID: 17318853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
    Christante D; Pommier S; Givi B; Pommier R
    Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic arterial chemoembolization for hepatocellular carcinoma and metastatic neuroendocrine tumors in the era of liver transplantation.
    Martin M; Tarara D; Wu YM; Ukah F; Fabrega A; Corwin C; Lang E; Mitros F
    Am Surg; 1996 Sep; 62(9):724-32. PubMed ID: 8751763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
    Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
    J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine liver metastases.
    Reddy SK; Clary BM
    Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
    Berber E; Flesher N; Siperstein AE
    World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review.
    Bruzoni M; Parikh P; Celis R; Are C; Ly QP; Meza JL; Sasson AR
    Am J Surg; 2009 Mar; 197(3):376-81. PubMed ID: 19245918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
    Hengst K; Nashan B; Avenhaus W; Ullerich H; Schlitt HJ; Flemming P; Pichlmayr R; Domschke W
    Z Gastroenterol; 1998 Mar; 36(3):239-45. PubMed ID: 9577908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
    Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
    Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
    Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
    Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.